Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
Conditions
Interventions
Intervention1: intervention agent- Group II: Trabecular implants will be placed in healthy individuals for management of edentulous sites in mandible
Intervention2: intervention agent- Group IV: Trab
Sponsors
Geetha Arul Mohan
SRM Dental College
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for diabetic individuals: 1. diabetic patients with HbA1C: 6.1-8 [Group III and group IV] 2. Patients who are between 18-60 years of age 3. All sites had to be healed sites, that is at least 6 months of post extraction healing was required 4. Mandibular edentulous sites Inclusion criteria for healthy individuals: 1. Non diabetic patients with HbA1C- less than 6.1 [Group I and group II] 2. Patients who are between 18-60 years of age 3. All sites had to be healed sites, that is at least 6 months of post extraction healing was required 4. Mandibular edentulous sites
Exclusion criteria
Exclusion criteria: Exclusion criteria for diabetic individuals: 1. HbA1C levels exceeding 8 are excluded 2. History of oral /intravenous bisphosphonate use for >3 years 3. Smokers 4. Pregnancy or lactation 5. Known allergy to any material or medication used in the study 6. Any Previous History of head and neck radiation therapy 7. Chemotherapy in the last 12 months 8. Severe psychologic problems 9. Patient not willing to sign the consent approved by the Human Studies Committee 10. Debilitating systemic diseases or conditions that have a clinically significant effect on wound healing Exclusion criteria for healthy individuals: 1. HbA1C levels exceeding 6.1 are excluded[Group I and group II] 2. History of oral /intravenous bisphosphonate use for >3 years 3. Smokers 4. Pregnancy or lactation 5. Known allergy to any material or medication used in the study 6. Any Previous History of head and neck radiation therapy 7. Chemotherapy in the last 12 months 8. Severe psychologic problems 9. Patient not willing to sign the consent approved by the Human Studies Committee 10. Debilitating systemic diseases or conditions that have a clinically significant effect on wound
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of secondary stability using Resonance frequency analyser in healthy and diabetic individualsTimepoint: subjects will be followed at baseline, 2 and 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of Primary stability and Crestal bone levels in healthy and diabetic individualsTimepoint: subjects will be followed at baseline, 2 and 4 months | — |
Countries
India
Contacts
Public ContactGeetha Arul Mohan
SRM university
Outcome results
None listed